Mercer Global Advisors Inc Edwards Lifesciences Corp Transaction History

Mercer Global Advisors Inc

$39.5 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $167,727 - $211,351	-2,718 Reduced 4.88%	52,934 $4.04 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $3.86 Million - $5.2 Million	55,652 New	55,652 $3.86 Million
Q4 2022 Feb 08, 2023	SELL	$68.3 - $87.44 $262,067 - $335,507	-3,837 Reduced 8.04%	43,881 $3.27 Million
Q3 2022 Nov 15, 2022	SELL	$82.37 - $107.29 $135,333 - $176,277	-1,643 Reduced 3.33%	47,718 $3.94 Million
Q2 2022 Aug 10, 2022	BUY	$86.5 - $128.27 $112,969 - $167,520	1,306 Added 2.72%	49,361 $4.69 Million
Q1 2022 May 10, 2022	BUY	$101.96 - $128.34 $685,986 - $863,471	6,728 Added 16.28%	48,055 $5.66 Million
Q4 2021 Feb 04, 2022	BUY	$106.37 - $130.68 $274,860 - $337,677	2,584 Added 6.67%	41,327 $5.35 Million
Q3 2021 Nov 10, 2021	SELL	$102.91 - $122.75 $332,296 - $396,359	-3,229 Reduced 7.69%	38,743 $4.39 Million
Q2 2021 Aug 10, 2021	SELL	$83.84 - $104.76 $72,270 - $90,303	-862 Reduced 2.01%	41,972 $4.35 Million
Q1 2021 Aug 10, 2021	BUY	$78.68 - $90.67 $255,316 - $294,224	3,245 Added 8.2%	42,834 $3.58 Million
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $482,229 - $555,716	-6,129 Reduced 13.41%	39,589 $3.31 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $903,437 - $1.15 Million	12,602 Added 38.05%	45,718 $4.17 Million
Q3 2020 Dec 10, 2020	BUY	$67.19 - $87.44 $72,027 - $93,735	1,072 Added 3.35%	33,116 $2.64 Million
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $1.41 Million - $1.88 Million	24,484 Added 323.86%	32,044 $2.22 Million
Q1 2020 May 18, 2020	BUY	$52.41 - $81.0 $205,237 - $317,196	3,916 Added 107.46%	7,560 $1.43 Million
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $14,196 - $16,253	-198 Reduced 5.15%	3,644 $850,000
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $5,416 - $6,637	-88 Reduced 2.24%	3,842 $844,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $66,999 - $77,420	-1,202 Reduced 23.42%	3,930 $726,000
Q1 2019 Apr 23, 2019	SELL	$47.89 - $64.05 $17,910 - $23,954	-374 Reduced 6.79%	5,132 $982,000
Q1 2019 Apr 12, 2019	BUY	$47.89 - $64.05 $263,682 - $352,659	5,506 New	5,506 $843,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account